Literature DB >> 15483659

Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.

I Zineh1, T Gerhard, C L Aquilante, A L Beitelshees, B N Beasley, A G Hartzema.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15483659     DOI： 10.1038/sj.tpj.6500284

Source DB:  PubMed          Journal:  Pharmacogenomics J        ISSN： 1470-269X            Impact factor:   3.550


× No keyword cloud information.
  11 in total

1.  Pharmacogenomics, evidence, and the role of payers.

Authors:  P A Deverka
Journal:  Public Health Genomics       Date:  2009-02-10       Impact factor: 2.000

2.  Screening for 392 polymorphisms in 141 pharmacogenes.

Authors:  Jason Yongha Kim; Hyun Sub Cheong; Tae-Joon Park; Hee Jung Shin; Doo Won Seo; Han Sung Na; Myeon Woo Chung; Hyoung Doo Shin
Journal:  Biomed Rep       Date:  2014-04-30

3.  An evaluation of pharmacogenomic information provided by five common drug information resources.

Authors:  K T L Vaughan; Kelly L Scolaro; Heidi N Anksorus; Mary W Roederer
Journal:  J Med Libr Assoc       Date:  2014-01

4.  Comparing cytochrome P450 pharmacogenetic information available on United States drug labels and European Union Summaries of Product Characteristics.

Authors:  J Reis-Pardal; A Rodrigues; E Rodrigues; F Fernandez-Llimos
Journal:  Pharmacogenomics J       Date:  2016-05-31       Impact factor: 3.550

Review 5.  [Implications of pharmacogenetics in every-day practice].

Authors:  T Gerloff; I Roots
Journal:  Internist (Berl)       Date:  2005-11       Impact factor: 0.743

6.  Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists.

Authors:  Rachel Mills; Susanne B Haga
Journal:  Pharmacogenomics       Date:  2013-06       Impact factor: 2.533

7.  Feasibility of incorporating genomic knowledge into electronic medical records for pharmacogenomic clinical decision support.

Authors:  Casey Lynnette Overby; Peter Tarczy-Hornoch; James I Hoath; Ira J Kalet; David L Veenstra
Journal:  BMC Bioinformatics       Date:  2010-10-28       Impact factor: 3.169

8.  Survey of US public attitudes toward pharmacogenetic testing.

Authors:  S B Haga; J M O'Daniel; G M Tindall; I R Lipkus; R Agans
Journal:  Pharmacogenomics J       Date:  2011-02-15       Impact factor: 3.550

9.  Insurance coverage policies for personalized medicine.

Authors:  Andrew Hresko; Susanne B Haga
Journal:  J Pers Med       Date:  2012-10-30

10.  Pharmacogenetic information in Swiss drug labels - a systematic analysis.

Authors:  C Jeiziner; K Suter; U Wernli; J M Barbarino; L Gong; M Whirl-Carrillo; T E Klein; T D Szucs; K E Hersberger; H E Meyer Zu Schwabedissen
Journal:  Pharmacogenomics J       Date:  2020-10-17       Impact factor: 3.550
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.